FIELD: medicine.
SUBSTANCE: method is implemented by blood analysis for total and free triiodothyronine after the termination of integrated treatment to derive the total to free triiodothyronine ratio, and it is within the range 0.26-0.31, steady state is predicted to be kept in the patients; the ratio within the range 0.19-0.22 ensures to predict the disease generalisation. Technical and economic efficiency of the invention consists in the fact that the derived prognosis factor is an informative laboratory covariant of the favourable or unfavourable development of the pathology.
EFFECT: clinical application of the method allows for well-timed administration of the appropriate treatment in the patient with high-risk early process generalisation.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING CHEMORADIOTHERAPY EFFICIENCY IN PATIENTS WITH DISSEMINATED SKIN MELANOMA | 2008 |
|
RU2398238C1 |
| METHOD OF PREDICTING OF PROCESS ACTIVATION IN PATIENTS WITH HODGKIN'S LYMPHOMA | 2009 |
|
RU2405454C1 |
| METHOD FOR TREATING GENERALIZED SKIN MELANOMA | 2005 |
|
RU2301061C2 |
| METHOD OF PREDICTING DURATION OF RECURRENCE-FREE PERIOD IN RADICALLY TREATED PATIENTS WITH MAMMARY GLAND CANCER | 2009 |
|
RU2413231C2 |
| METHOD OF PROGNOSING GENERALIZATION OF PROCESS IN CHILDREN AND ADOLESCENTS WITH OSTEAL SARCOMA | 2004 |
|
RU2282195C2 |
| METHOD OF PROGNOSIS OF DISEASE COURSE IN PATIENTS WITH UTERINE BODY CANCER | 2008 |
|
RU2395097C1 |
| METHOD FOR PREDICTING RELAPSES IN SKIN MELANOMA PATIENTS | 2004 |
|
RU2275637C2 |
| METHOD FOR PREDICTION OF DEVELOPING METASTASES IN PATIETNS SUFFERING RECTAL CANCER | 2009 |
|
RU2420742C1 |
| METHOD OF ESTIMATING EFFICIENCY OF NEOADJUVANT AUTOHEMOCHEMOTHERAPY IN PATIENTS SUFFERING FROM CARCINOMA OF CERVIVAL STUMP | 2008 |
|
RU2375063C1 |
| METHOD OF PREDICTING PROCESS GENERALISATION IN CASE OF MALIGNANT BONE TUMOURS | 2010 |
|
RU2427323C1 |
